medrxiv
preprint
infect
patient
activ
latent
tb
suscept
symptom
develop
progress
rapid
sever
mean
tuberculosi
statu
assess
care
patient
admiss
manag
therapeut
strategi
adjust
accordingli
prevent
rapid
develop
sever
complic
import
risk
factor
associ
viral
pneumonia
origin
wuhan
china
dec
requir
clarif
medic
resourc
priorit
highest
risk
sever
complic
infect
tuberculosi
mtb
pathogen
caus
tb
latent
infect
global
popul
may
risk
factor
infect
sever
pneumonia
object
determin
latent
activ
tb
increas
suscept
infect
diseas
sever
lead
rapid
develop
pneumonia
viral
pneumonia
emerg
wuhan
china
decemb
spread
throughout
china
countri
date
mar
confirm
case
worldwid
death
pose
major
threat
global
health
declar
public
health
emerg
intern
concern
jan
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
infect
gener
popul
result
mild
symptom
individu
underli
comorbid
particularli
elderli
vulner
infect
requir
addit
care
import
gain
clear
pictur
risk
factor
associ
new
viral
respiratori
infect
order
alloc
appropri
medic
resourc
prevent
develop
sever
critic
form
consid
higher
risk
consid
possibl
infect
mycobacterium
tuberculosi
pathogen
caus
tuberculosi
tb
top
caus
death
due
infecti
diseas
may
predispos
sarscov
infect
rapid
develop
symptom
sever
pneumonia
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
guidelin
nation
health
commiss
china
includ
studi
demograph
data
shown
supplementari
tabl
studi
approv
ethic
committe
shenyang
chest
hospit
inform
written
consent
obtain
studi
particip
throat
swab
blood
sputum
collect
suspect
patient
sent
test
use
realtim
reversetranscript
polymeras
chain
reaction
assay
shenyang
diseas
control
center
igra
assay
igra
assay
perform
use
xdottb
kit
tb
healthcar
foshan
china
accord
manufactur
instruct
analys
perform
use
r
version
normal
data
distribut
assess
use
kolmogorovsmirnov
test
normallydistribut
data
present
mean
sd
nonnorm
distribut
data
present
median
iqr
categor
variabl
frequenc
differ
group
analys
fisher
exact
test
pearson
chisquar
test
categor
data
student
ttest
mannwhitney
test
continu
data
among
confirm
patient
shenyang
liaon
provinc
china
includ
studi
common
symptom
present
cough
dyspnea
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
fever
lymphopenia
fatigu
tabl
mean
age
patient
year
rang
men
fifteen
case
connect
wuhanhubei
provinc
neighbor
citi
becom
infect
via
local
transmiss
friendsfamili
member
shenyang
alreadi
diagnos
evalu
implic
mtb
infect
histori
incid
progress
diseas
address
three
question
mtb
coinfect
increas
suscept
infect
increas
diseas
sever
lead
rapid
diseas
progress
first
assign
case
two
group
base
sever
pneumonia
accord
diagnost
treatment
guidelin
nation
health
commiss
china
twentyseven
case
mildmoder
group
nine
case
severecrit
group
tabl
determin
mtb
infect
statu
patient
examin
clinic
histori
perform
xdottb
igra
assay
tabl
determin
mtb
infect
risk
factor
specif
pneumonia
pneumonia
gener
compar
mtb
infect
rate
within
case
data
caseseri
compris
bacteri
pneumonia
viral
pneumonia
patient
obtain
anoth
studi
conduct
shenyang
unpublish
figur
mtb
infect
rate
consider
higher
among
patient
among
bacteri
pneumonia
patient
vs
p
figur
viral
pneumonia
patient
vs
p
suggest
mtb
infect
statu
specif
risk
factor
infect
rather
pneumonia
gener
rate
mtb
infect
bacteri
viral
pneumonia
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
patient
significantli
differ
approxim
gener
popul
percentag
patient
mtb
infect
also
consider
higher
percentag
patient
comorbid
diabet
hypertens
coronari
heart
diseas
copd
tabl
suggest
mtb
infect
repres
higher
risk
infect
respect
diseas
sever
percentag
severecrit
case
mtb
coinfect
significantli
higher
mildmoder
group
vs
p
figur
seven
severecrit
case
igrav
indic
mtb
coinfect
case
develop
ard
igrav
comparison
case
group
mildmoder
case
igrav
histori
tb
diseas
data
infer
coinfect
mtb
tend
lead
develop
sever
critic
symptom
data
also
show
mtb
infect
associ
rapid
develop
symptom
figur
mtb
coinfect
case
develop
symptom
averag
day
earlier
nonmtbinfect
counterpart
develop
critic
symptom
report
occur
averag
day
initi
symptom
onset
mtbinfect
severecrit
case
howev
categor
severecrit
day
initi
symptom
develop
number
case
suffici
draw
solid
conclus
would
appear
diseas
progress
rapidli
presenc
mtb
coinfect
observ
studi
relationship
mtb
infect
pneumonia
suggest
individu
latent
activ
tb
may
suscept
infect
diseas
progress
may
rapid
sever
given
tb
caus
death
infecti
diseas
million
death
million
new
case
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
global
rate
ltbi
estim
high
find
cautionari
remind
clinician
mtb
infect
statu
consid
treat
patient
order
prevent
rapid
deterior
patient
health
data
suggest
mtb
infect
could
import
risk
factor
comorbid
commonli
report
epidemiolog
studi
diabet
hypertens
tb
respiratori
diseas
perhap
surpris
chronic
respiratori
diseas
chronic
obstruct
pulmonari
diseas
copd
inde
activ
tb
could
predispos
suscept
statist
report
studi
howev
suggest
frequenc
comorbid
much
lower
mtb
infect
studi
copd
case
chronic
respiratori
diseas
case
strength
find
howev
limit
rel
low
number
case
involv
studi
requir
valid
base
find
make
follow
recommend
manag
treatment
patient
histori
mtb
infect
ltbi
activ
tb
possibl
coinfect
first
medic
wider
commun
inform
latentact
tb
risk
factor
infect
risk
encourag
pay
special
attent
prevent
measur
ideal
vulner
group
monitor
regularli
communitybas
medic
center
situat
resourc
avail
second
mtb
infect
statu
histori
igra
respons
suspectedconfirm
case
check
routin
admiss
ensur
coinfect
case
place
appropri
isol
ward
activ
tb
detect
third
special
medic
resourc
ecmo
therapi
arrang
advanc
coinfect
patient
view
increas
likelihood
rapid
develop
sever
critic
symptom
fourth
therapeut
approach
case
known
coinfect
mtb
bear
mtb
infect
histori
mind
exampl
treatment
involv
immunosuppress
agent
reconsid
hold
potenti
reactiv
latent
tb
infect
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
comparison
group
made
use
fisher
exact
test
n
mannwhitney
test
n
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
data
mean
sd
n
signific
differ
group
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
